Impact Factor 2023

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3086

PDF: 2190
Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

158-165

19-07-2012

https://doi.org/10.4081/reumatismo.2012.158

1042

PDF: 814
Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

388-394

20-12-2012

https://doi.org/10.4081/reumatismo.2012.388

4166

PDF: 2275
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2617

PDF: 1353
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases

L. Degli Esposti, L. Sinigaglia, M. Rossini, S. Adami, C. Cagnoni, C. Magliaro, C. Veronesi, S. Buda, S. Minisola

18-26

16-03-2012

https://doi.org/10.4081/reumatismo.2012.18

1570

PDF: 940
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

188-194

31-12-2016

https://doi.org/10.4081/reumatismo.2016.903

1729

PDF: 912
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

30-39

22-05-2017

https://doi.org/10.4081/reumatismo.2017.922

4431

PDF: 2986
A case of mandible Paget’s disease of the bone treated with intravenous neridronate

A. Fassio, L. Idolazzi, M. Rossini, O. Viapiana, D. Gatti

154-158

16-12-2016

https://doi.org/10.4081/reumatismo.2016.917

2003

PDF: 1024
Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

63-74

27-05-2013

https://doi.org/10.4081/reumatismo.2013.63

7271

PDF: 3813
Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

A. Loi, S. Lisci, A. Denotti, A. Cauli

121-125

24-07-2013

https://doi.org/10.4081/reumatismo.2013.121

2868

PDF: 1030
Short story of antirheumatic therapy.VIII. The immunodepressants

G. Pasero, P. Marson

44-54

19-03-2012

https://doi.org/10.4081/reumatismo.2012.44

1532

PDF: 1468
Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment

G. Farronato, C. Bellintani, U. Garagiola, P. Cressoni, P. Sarzi Puttini, F. Atzeni, M. Cazzola

254-257

06-11-2014

https://doi.org/10.4081/reumatismo.2014.725

2484

PDF: 1284
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

7019

PDF: 2514
Update on treatment of polymyalgia rheumatica

D. Camellino, C. Dejaco

59-66

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1062

5780

PDF: 3354
Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

O. Di Munno, A. Delle Sedie

67-79

https://doi.org/10.4081/reumatismo.2011.67

1546

PDF: 921
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

78-84

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1011

2484

PDF: 1299
Possible relationship between certolizumab pegol and arrhythmias: report of two cases

R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

104-108

09-09-2016

https://doi.org/10.4081/reumatismo.2016.869

1538

PDF: 939
Work-related carpal tunnel syndrome treatment: a cross-sectional study among 106 patients

M. Aouatef, B. Asma, H. Hajer, A. Charfeddine, B. Lamia, K. Taoufik

59-64

03-08-2017

https://doi.org/10.4081/reumatismo.2017.978

2636

PDF: 1216
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

350-359

20-12-2012

https://doi.org/10.4081/reumatismo.2012.350

3050

PDF: 2615
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs

E. Lubrano, R. Scarpa

107-112

05-06-2012

https://doi.org/10.4081/reumatismo.2012.107

1359

PDF: 1196
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients

S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo

326-334

11-12-2012

https://doi.org/10.4081/reumatismo.2012.326

1687

PDF: 798
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

208-214

06-11-2014

https://doi.org/10.4081/reumatismo.2014.756

2638

PDF: 1442
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

40-43

19-03-2012

https://doi.org/10.4081/reumatismo.2012.40

949

PDF: 1522
Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran

D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, M.S. Soleymani

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1540

1468

PDF: 680
Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

B.D. Nielsen, B. Dasgupta

1-9

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1070

2117

PDF: 1552
Emerging therapies for osteoporosis

G. Minisola, A. Iuliano, I. Prevete

112-124

28-07-2014

https://doi.org/10.4081/reumatismo.2014.784

1837

PDF: 1365
Duration of treatment for osteoporosis

Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

22-35

28-03-2013

https://doi.org/10.4081/reumatismo.2013.22

3550

PDF: 1240
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis

A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti

65-71

09-09-2016

https://doi.org/10.4081/reumatismo.2016.878

1871

PDF: 1061
Comorbidity in polymyalgia rheumatica

C. Chatzigeorgiou, S.L. Mackie

35-43

27-03-2018

https://doi.org/10.4081/reumatismo.2018.1039

3473

PDF: 2032
Pain in rheumatoid arthritis: a critical review

P. Sarzi-Puttini, F. Salaffi, M. Di Franco, L. Bazzichi, G. Cassisi, R. Casale, M. Cazzola, S. Stisi, M. Battellino, F. Atzeni

18-27

06-06-2014

https://doi.org/10.4081/reumatismo.2014.760

5887

PDF: 3498
Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review

A. Minelli, A. Vaona

151-157

19-07-2012

https://doi.org/10.4081/reumatismo.2012.151

2341

PDF: 1458
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2292

PDF: 1544
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2540

PDF: 1202
Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

97-102

09-02-2016

https://doi.org/10.4081/reumatismo.2015.829

2093

PDF: 1243
Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

286-291

17-03-2014

https://doi.org/10.4081/reumatismo.2013.691

2565

PDF: 1175
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

109-111

09-09-2016

https://doi.org/10.4081/reumatismo.2016.889

1812

PDF: 1154
Bradykinin and its role in osteoarthritis

L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti

97-104

23-07-2013

https://doi.org/10.4081/reumatismo.2013.97

3166

PDF: 1842
Guidelines on prevention and treatment of vitamin D deficiency

S. Adami, E. Romagnoli, V. Carnevale, A. Scillitani, A. Giusti, M. Rossini, D. Gatti, R. Nuti, S. Minisola

129-147

09-11-2011

https://doi.org/10.4081/reumatismo.2011.129

10556

PDF: 32736
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

93-102

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1235

884

PDF: 567
Sarcoidosis presenting as orbital pseudotumor

S. Kobak, A. Topaloglu, G. Öncel, A. Karaarslan

78-81

16-09-2015

https://doi.org/10.4081/reumatismo.2015.832

1870

PDF: 1018
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1227

PDF: 1032
Male osteoporosis

A. Giusti, G. Bianchi

136-143

28-07-2014

https://doi.org/10.4081/reumatismo.2014.786

2624

PDF: 1557
Management of cutaneous discomfort in patients with scleroderma: a clinical trial

M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

240-247

18-12-2013

https://doi.org/10.4081/reumatismo.2013.240

3260

PDF: 1035
Octogenarian with an untreated femoral neck fracture: upright position during the postoperative course after aortic valve replacement

M. Polastri, L. Di Marco, S. Cantagalli, M. Di Eusanio

26-28

30-06-2015

https://doi.org/10.4081/reumatismo.2015.797

1310

PDF: 716
Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

121-126

https://doi.org/10.4081/reumatismo.2006.121

1719

PDF: 1680
Effects of secukinumab on serum adipocytokines: preliminary data

A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi

105-110

21-09-2017

https://doi.org/10.4081/reumatismo.2017.953

2725

PDF: 1411
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi

163-165

16-12-2016

https://doi.org/10.4081/reumatismo.2016.911

3038

PDF: 782
Guidelines for the diagnosis, prevention and management of osteoporosis

M. Rossini, S. Adami, F. Bertoldo, D. Diacinti, D. Gatti, S. Giannini, A. Giusti, N. Malavolta, S. Minisola, G. Osella, M. Pedrazzoni, L. Sinigaglia, O. Viapiana, G. C. Isaia

1-39

23-06-2016

https://doi.org/10.4081/reumatismo.2016.870

19216

PDF: 9322
Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study)

E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado

22-11-2021

https://doi.org/10.4081/reumatismo.2021.1400

2475

PDF: 644
Familial Mediterranean fever without cardinal symptoms and role of genetic screening

T. Ulas, H. Buyukhatipoglu, C. Bes, M.S. Dal, I. Hacıbekiroglu, H.G. Apucu, F. Borlu

172-174

19-07-2012

https://doi.org/10.4081/reumatismo.2012.172

764

PDF: 792

1 - 50 of 369 items 1 2 3 4 5 6 7 8 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy